about
Amiodarone versus other pharmacological interventions for prevention of sudden cardiac deathThe problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin AmericaManagement of nonalcoholic fatty liver disease: an evidence-based clinical practice review.Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease.[Chilean consensus of prevention, diagnosis and treatment of Clostridium difficile-associated diarrhea].[Why is it essential to randomize a clinical trial on therapy?].[Confidence intervals]Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease
P50
Q24187185-151182B9-8F2C-46FF-8005-CAC2C1836E37Q30217199-05368539-A526-4605-ADDD-BBDE812275F7Q34168532-925B7F26-5297-4465-B699-AFD89DB6A8DEQ37625290-3BE27CE0-E3B3-4872-B433-EF826ED8FB9EQ40759749-69EA3C5B-0C94-4EAD-9298-87D1F73FC391Q45102062-B291CE16-6958-4D7A-9999-D107974D3C57Q81538405-169D9047-E6DA-4E59-ABFF-68FDEE749F35Q82780472-6B31E6DB-86A9-4749-8D74-A187F770F263
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Roberto Candia
@en
Roberto Candia
@nl
type
label
Roberto Candia
@en
Roberto Candia
@nl
prefLabel
Roberto Candia
@en
Roberto Candia
@nl
P31
P496
0000-0003-1856-7737